Novel crystalline forms of a vegf-r inhibitor
The present invention relates to novel crystalline polymorphic and amorphous form of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole and to methods for their preparation. The invention is also directed to pharmaceutical compositions containing at least one polymorphic for...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
21.04.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to novel crystalline polymorphic and amorphous form of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole and to methods for their preparation. The invention is also directed to pharmaceutical compositions containing at least one polymorphic form and to the therapeutic or prophylactic use of such polymorphic forms and compositions. |
---|---|
Bibliography: | Application Number: TW200897112383 |